Target intelligence / Profile preview

Hydrophobic small molecules

Molecular classification
Other
01

Overview

Hydrophobic small molecules are nonpolar molecules that do not mix or dissolve in water due to their inability to form hydrogen bonds, and instead tend to aggregate or partition into non-aqueous (organic) phases[1][7]. Common examples include hydrocarbons, steroids, fats, and many pharmaceutical drugs[7][5]. Their hydrophobic nature is largely determined by their structure—typically rich in C–H bonds, lacking significant polarity, and without hydrogen-bond donors or acceptors[7][5][1]. In biology, hydrophobic small molecules play essential roles in membrane structure, metabolic energy storage, chemical signaling (e.g., steroid hormones), and as a key driving force in protein folding and molecular recognition via the hydrophobic effect[3][5][8][2]. In drug discovery and delivery, the hydrophobicity of small molecules strongly influences absorption, distribution, metabolism, excretion, and toxicity (ADMET); while desirable for membrane permeation, excessive hydrophobicity can lead to low solubility, non-specific binding, and off-target toxicities[4][9][8]. "Hydrophobic small molecules" is not itself a drug target, but a broad chemical descriptor. There is no specific "canonical" target associated with the term "hydrophobic small molecules," and the name itself is unsuitable for use as a structured therapeutic target.

Other names
Hydrophobic moleculenonpolar small moleculelipophilic small molecule
02

Mechanism of action

Null (not applicable; hydrophobic small molecules are not therapeutic targets, but rather act by various mechanisms depending on their structure and context.)

03

Biological functions

Structural component (e.g., membrane lipids)Participation in energy storage (e.g., triglycerides)Mediation of cell signaling (e.g., steroid hormones)Protein folding and molecular recognition (as hydrophobic effect)Other
04

Disease associations

Other (can be involved in pathophysiology as components of drugs, lipids, toxins, etc.)
05

Safety considerations

Poor aqueous solubility can limit bioavailability and therapeutic use[4].Non-specific binding to proteins, membranes, or off-target sitesPotential for toxicity via accumulation or aggregation

Beyond the preview

Go deeper on Hydrophobic small molecules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hydrophobic small molecules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call